SIRT1: new avenues of discovery for disorders of oxidative stress

Bibliography

• Hou J, Chong ZZ, Shang YC, Maiese K. FoxO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling. Mol Cell Endocrinol 2010;321:194-206
   PubMedGoogle Scholar
• Hou J, Chong ZZ, Shang YC, Maiese K. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res 2010;7:95-112
   PubMed Web of Science ®Google Scholar
• Zhang T, Berrocal JG, Frizzell KM, Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 2009;284:20408-17
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Pullmann R Jr, Lal A, Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 2007;25:543-57
   PubMed Web of Science ®Google Scholar
• Kim EJ, Kho JH, Kang MR, Um SJ. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 2007;28:277-90
   PubMed Web of Science ®Google Scholar
• Kim JE, Chen J, Lou Z. DBC1 is a negative regulator of SIRT1. Nature 2008;451:583-6
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Hou J, Shang YC. Oxidative stress: biomarkers and novel therapeutic pathways. Exp Gerontol 2010;45:217-34
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Hou J, Shang YC. The vitamin nicotinamide: translating nutrition into clinical care. Molecules 2009;14:3446-85
   PubMed Web of Science ®Google Scholar
• Lin J, Zheng S, Chen A. Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress. Lab Invest 2009;89:1397-409
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Li F, Shang YC. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol 2008;85:194-213
   PubMed Web of Science ®Google Scholar
• Tupe RS, Tupe SG, Agte VV. Dietary nicotinic acid supplementation improves hepatic zinc uptake and offers hepatoprotection against oxidative damage. Br J Nutr 2011;105:1741-9
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol 2007;22:1251-67
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Shang YC, Hou J, Maiese K. Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways. Oxid Med Cell Longev 2010;3:153-65
   PubMed Web of Science ®Google Scholar
• Ghosh N, Ghosh R, Mandal SC. Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease. Free Radic Res 2011;45:888-905
   PubMed Web of Science ®Google Scholar
• Jourde-Chiche N, Dou L, Cerini C, Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Semin Dial 2011;24:327-37
   PubMedGoogle Scholar
• Komandirov MA, Knyazeva EA, Fedorenko YP, On the role of phosphatidylinositol 3-kinase, protein kinase b/akt, and glycogen synthase kinase-3beta in photodynamic injury of crayfish neurons and glial cells. J Mol Neurosci 2011;45:229-35
   PubMedGoogle Scholar
• Chong ZZ, Li F, Maiese K. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. Cell Signal 2007;19:1150-62
   PubMed Web of Science ®Google Scholar
• Shang YC, Chong ZZ, Hou J, Maiese K. The forkhead transcription factor FoxO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. Curr Neurovasc Res 2009;6:20-31
   PubMedGoogle Scholar
• Chong ZZ, Hou J, Shang YC, EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3beta, and beta-catenin to foster vascular integrity during experimental diabetes. Curr Neurovasc Res 2011;8:103-20
   PubMed Web of Science ®Google Scholar
• Schutters K, Reutelingsperger C. Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis 2010;15:1072-82
   PubMed Web of Science ®Google Scholar
• Shang YC, Chong ZZ, Wang S, Maiese K. Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. Curr Neurovasc Res 2011;8:270-85
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Shang YC. OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol Med 2008;14:219-27
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Shang YC, Hou J. A "FOXO" in sight: targeting Foxo proteins from conception to cancer. Med Res Rev 2009;29:395-418
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Wakino S, Yoshioka K, Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun 2008;372:51-6
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Lin SH, Li F, Maiese K. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through Akt, Bad, PARP, and mitochondrial associated "anti-apoptotic" pathways. Curr Neurovasc Res 2005;2:271-85
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Maiese K. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr Neurovasc Res 2008;5:159-70
   PubMed Web of Science ®Google Scholar
• Tanno M, Kuno A, Yano T, Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 2010;285:8375-82
   PubMed Web of Science ®Google Scholar
• Kume S, Haneda M, Kanasaki K, Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic Biol Med 2006;40:2175-82
   PubMed Web of Science ®Google Scholar
• Hou J, Wang S, Shang YC, Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress. Curr Neurovasc Res 2011;8:220-35
   PubMed Web of Science ®Google Scholar
• Audrito V, Vaisitti T, Rossi D, Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res 2011;71:4473-83
   PubMed Web of Science ®Google Scholar
• Balan V, Miller GS, Kaplun L, Life span extension and neuronal cell protection by Drosophila nicotinamidase. J Biol Chem 2008;283:27810-19
   PubMed Web of Science ®Google Scholar
• Solomon JM, Pasupuleti R, Xu L, Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol 2006;26:28-38
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Shang YC. Raves and risks for erythropoietin. Cytokine Growth Factor Rev 2008;19:145-55
   PubMed Web of Science ®Google Scholar
• Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. Jama 2005;293:90-5
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002;106:2973-9
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Kang JQ, Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 2002;22:503-14
   PubMedGoogle Scholar
• Kaushal N, Hegde S, Lumadue J, The regulation of erythropoiesis by selenium in mice. Antioxid Redox Signal 2011;14:1403-12
   PubMedGoogle Scholar
• Kumral A, Tuzun F, Oner MG, Erythropoietin in neonatal brain protection: the past, the present and the future. Brain Dev 2011;33:632-43
   PubMed Web of Science ®Google Scholar
• Lanfranconi S, Locatelli F, Corti S, Growth factors in ischemic stroke. J Cell Mol Med 2011;15:1645-87
   PubMed Web of Science ®Google Scholar
• Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin: a hormone with multiple functions. Pathobiology 2011;78:41-53
   PubMedGoogle Scholar
• Maiese K, Chong ZZ, Hou J, Shang YC. Erythropoietin and oxidative stress. Curr Neurovasc Res 2008;5:125-42
   PubMed Web of Science ®Google Scholar
• Maiese K, Hou J, Chong ZZ, Shang YC. Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. ScientificWorldJournal 2009;9:1072-104
   PubMedGoogle Scholar
• Mastromarino V, Volpe M, Musumeci MB, Erythropoietin and the heart: facts and perspectives. Clin Sci (Lond) 2011;120:51-63
   PubMed Web of Science ®Google Scholar
• Moore EM, Bellomo R, Nichol AD. Erythropoietin as a novel brain and kidney protective agent. Anaesth Intensive Care 2011;39:356-72
   PubMed Web of Science ®Google Scholar
• Murua A, Orive G, Hernandez RM, Pedraz JL. Emerging technologies in the delivery of erythropoietin for therapeutics. Med Res Rev 2011;31:284-309
   PubMed Web of Science ®Google Scholar
• Orimo M, Minamino T, Miyauchi H, Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler Thromb Vasc Biol 2009;29:889-94
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Pillai VB, Wolfgeher D, The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal 2011;4:ra46
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Milne JC, Imamura T, SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009;29:1363-74
   PubMed Web of Science ®Google Scholar
• Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal 2011;14:593-605
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Furukawa-Hibi Y, Chen C, SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med 2005;16:237-43
   PubMed Web of Science ®Google Scholar
• Daitoku H, Hatta M, Matsuzaki H, Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 2004;101:10042-7
   PubMed Web of Science ®Google Scholar
• Alcendor RR, Gao S, Zhai P, Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007;100:1512-21
   PubMed Web of Science ®Google Scholar
• Hariharan N, Maejima Y, Nakae J, Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ Res 2010;107:1470-82
   PubMed Web of Science ®Google Scholar
• Xiong S, Salazar G, Patrushev N, Alexander RW. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J Biol Chem 2011;286:5289-99
   PubMed Web of Science ®Google Scholar
• Nemoto S, Fergusson MM, Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004;306:2105-8
   PubMed Web of Science ®Google Scholar
• Nowak K, Killmer K, Gessner C, Lutz W. E2F-1 regulates expression of FOXO1 and FOXO3a. Biochim Biophys Acta 2007;1769:244-52
   PubMedGoogle Scholar
• Ganapathy S, Chen Q, Singh KP, Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One 2010;5:e15627
   PubMed Web of Science ®Google Scholar
• Wang C, Chen L, Hou X, Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 2006;8:1025-31
   PubMed Web of Science ®Google Scholar
• Albani D, Polito L, Batelli S, The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1–42) peptide. J Neurochem 2009;110:1445-56
   PubMed Web of Science ®Google Scholar
• Lu KT, Chiou RY, Chen LG, Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agric Food Chem 2006;54:3126-31
   PubMed Web of Science ®Google Scholar
• Simao F, Matte A, Matte C, Resveratrol prevents oxidative stress and inhibition of Na+K+-ATPase activity induced by transient global cerebral ischemia in rats. J Nutr Biochem 2011;22:921-8
   PubMed Web of Science ®Google Scholar
• Michan S, Li Y, Chou MM, SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010;30:9695-707
   PubMed Web of Science ®Google Scholar
• Julien C, Tremblay C, Emond V, Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 2009;68:48-58
   PubMed Web of Science ®Google Scholar
• Kim D, Nguyen MD, Dobbin MM, SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. Embo J 2007;26:3169-79
   PubMed Web of Science ®Google Scholar
• Donmez G, Wang D, Cohen DE, Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010;142:320-32
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 2005;75:207-46
   PubMed Web of Science ®Google Scholar
• Lu KT, Ko MC, Chen BY, Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 2008;56:6910-13
   PubMed Web of Science ®Google Scholar
• Khan MM, Ahmad A, Ishrat T, Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 2010;1328:139-51
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Li F, Maiese K. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2005;2:387-99
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Li F, Maiese K. The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. Int J Mol Med 2007;19:263-72
   PubMedGoogle Scholar
• Yeung F, Hoberg JE, Ramsey CS, Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 2004;23:2369-80
   PubMed Web of Science ®Google Scholar
• Teng FY, Tang BL. NF-kappaB signaling in neurite growth and neuronal survival. Rev Neurosci 2010;21:299-313
   PubMedGoogle Scholar
• Melnik BC, John SM, Schmitz G. Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome. Nutr Metab (Lond) 2011;8:41
   Google Scholar
• Zhang QJ, Wang Z, Chen HZ, Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 2008;80:191-9
   PubMed Web of Science ®Google Scholar
• Mattagajasingh I, Kim CS, Naqvi A, SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007;104:14855-60
   PubMed Web of Science ®Google Scholar
• El-Mowafy AM, Alkhalaf M, El-Kashef HA. Resveratrol reverses hydrogen peroxide-induced proliferative effects in human coronary smooth muscle cells: a novel signaling mechanism. Arch Med Res 2008;39:155-61
   PubMed Web of Science ®Google Scholar
• Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011;10:640-7
   PubMed Web of Science ®Google Scholar
• Cardellini M, Menghini R, Martelli E, TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 2009;58:2396-401
   PubMed Web of Science ®Google Scholar
• Hung LM, Su MJ, Chen JK. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 2004;36:774-81
   PubMed Web of Science ®Google Scholar
• Hsu CP, Zhai P, Yamamoto T, Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010;122:2170-82
   PubMed Web of Science ®Google Scholar
• Dernek S, Ikizler M, Erkasap N, Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia. Scand Cardiovasc J 2004;38:245-54
   PubMed Web of Science ®Google Scholar
• Fukuda S, Kaga S, Zhan L, Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 2006;44:43-9
   PubMed Web of Science ®Google Scholar
• Thandapilly SJ, Wojciechowski P, Behbahani J, Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 2010;23:192-6
   PubMed Web of Science ®Google Scholar
• Wojciechowski P, Juric D, Louis XL, Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats. J Nutr 2010;140:962-8
   PubMedGoogle Scholar
• Cheng TH, Liu JC, Lin H, Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn Schmiedebergs Arch Pharmacol 2004;369:239-44
   PubMed Web of Science ®Google Scholar
• Planavila A, Iglesias R, Giralt M, Villarroya F. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res 2011;90:276-84
   PubMed Web of Science ®Google Scholar
• Chan AY, Dolinsky VW, Soltys CL, Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 2008;283:24194-201
   PubMed Web of Science ®Google Scholar
• Maiese K, Chong ZZ, Shang YC, Hou J. Novel avenues of drug discovery and biomarkers for diabetes mellitus. J Clin Pharmacol 2011;51:128-52
   PubMed Web of Science ®Google Scholar
• Maiese K, Shang YC, Chong ZZ, Hou J. Diabetes mellitus: channeling care through cellular discovery. Curr Neurovasc Res 2010;7:59-64
   PubMed Web of Science ®Google Scholar
• Chen YR, Fang SR, Fu YC, Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats. Biochem Cell Biol 2010;88:715-22
   PubMedGoogle Scholar
• Sun C, Zhang F, Ge X, SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007;6:307-19
   PubMed Web of Science ®Google Scholar
• Li Y, Xu S, Giles A, Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. Faseb J 2011;25:1664-79
   PubMed Web of Science ®Google Scholar
• Picard F, Kurtev M, Chung N, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004;429:771-6
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-18
   PubMed Web of Science ®Google Scholar
• Purushotham A, Schug TT, Xu Q, Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009;9:327-38
   PubMed Web of Science ®Google Scholar
• Frojdo S, Durand C, Molin L, Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 2011;335:166-76
   PubMed Web of Science ®Google Scholar
• Bordone L, Motta MC, Picard F, Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006;4:e31
   PubMed Web of Science ®Google Scholar
• Vetterli L, Brun T, Giovannoni L, Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through Sirt1 dependent mechanism. J Biol Chem 2011;286:6049-60
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-42
   PubMed Web of Science ®Google Scholar
• Sasaki T, Kitamura T. Roles of FoxO1 and Sirt1 in the central regulation of food intake. Endocr J 2010;57:939-46
   PubMed Web of Science ®Google Scholar
• Ramadori G, Fujikawa T, Fukuda M, SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab 2010;12:78-87
   Google Scholar
• Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008;283:27628-35
   PubMed Web of Science ®Google Scholar
• Canto C, Auwerx J. Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab 2009;20:325-31
   PubMed Web of Science ®Google Scholar
• Fulco M, Cen Y, Zhao P, Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008;14:661-73
   PubMed Web of Science ®Google Scholar
• Herranz D, Serrano M. SIRT1: recent lessons from mouse models. Nat Rev Cancer 2010;10:819-23
   PubMed Web of Science ®Google Scholar
• Paiva MA, Rutter-Locher Z, Goncalves LM, Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2011;300:H2123-34
   Google Scholar
• Carvajal K, Zarrinpashneh E, Szarszoi O, Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2007;292:H3136-47
   Google Scholar
• Han L, Zhou R, Niu J, SIRT1 is regulated by a PPARgamma-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 2010;38:7458-71
   PubMed Web of Science ®Google Scholar
• Sugden MC, Caton PW, Holness MJ. PPAR control: it's SIRTainly as easy as PGC. J Endocrinol 2010;204:93-104
   PubMed Web of Science ®Google Scholar
• Nerurkar PV, Johns LM, Buesa LM, Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J Neuroinflammation 2011;8:64
   PubMed Web of Science ®Google Scholar
• Cheng Z, White MF. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 2011;14:649-61
   PubMed Web of Science ®Google Scholar
• Ferrara N, Rinaldi B, Corbi G, Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 2008;11:139-50
   PubMed Web of Science ®Google Scholar
• Chong ZZ, Li F, Maiese K. Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3. Curr Neurovasc Res 2006;3:25-39
   PubMedGoogle Scholar
• Wohlschlaeger J, Schmitz KJ, Takeda A, Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading. J Heart Lung Transplant 2010;29:117-24
   PubMedGoogle Scholar
• Chong ZZ, Shang YC, Zhang L, Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev 2010;3:374-91
   PubMed Web of Science ®Google Scholar